Lupin Limited has appointed Brian Savage as President and Chief Legal Officer. He will oversee the company’s global Legal, Compliance, and Intellectual Property Management Group (IPMG) functions and will be based in New Jersey.
Savage joins Lupin from Teva Pharmaceuticals, where he held several senior leadership positions since 2015, most recently serving as Executive Vice President and Interim Global Chief Legal Officer. He also led Teva’s global litigation strategy and served as General Counsel for its U.S. Generics business. Before joining Teva, he practised law at Dechert LLP.
Savage brings extensive experience in legal and regulatory matters within the global pharmaceutical industry. He holds a Juris Doctor degree from Yale Law School and a bachelor’s degree, summa cum laude, from the University of Pennsylvania.
Lupin CEO Vinita Gupta and Managing Director Nilesh Gupta said his industry knowledge, legal expertise and leadership experience would strengthen the company’s governance framework, help it navigate evolving regulatory requirements and support its long-term growth objectives.